Multibagger stock: Rs 1 lakh invested in this small-cap company a year ago would have multiplied more than 4 times

Multibagger stock: Rs 1 lakh invested in this small-cap company a year ago would have multiplied more than 4 times

by 5paisa Research Team Last Updated: Dec 13, 2022 - 12:26 pm 22.3k Views

From Rs 47 to Rs 207, this small-cap stock has quadrupled in a year.

Defying the market volatility, Panchsheel Organics has been trending upwards in the last 2 years giving 355% and 732% simple price returns in 1 and 2 years, respectively. This small-cap company is a manufacturer and exporter of Active Pharma Ingredients (APIs), Intermediates & Finished Formulations (both Human and Veterinary). 

The shares of Panchsheel Organics have outperformed the broad market index by a huge margin - with S&P BSE Smallcap remaining flat after a year and S&P BSE Healthcare has lost 13.8%.

  •  Rs 1,00,000 invested just 1 year ago would have become Rs 4,54,500 giving a price return of 355% and,

  • Rs 1,00,000 invested 2 years ago would have swelled to a mindboggling Rs 832,200 giving a price return of 732%.

Panchsheel Organics, a part of the Pharmaceutical Division of the Turakhia Brothers Group exports bulk actives to over 60 countries mainly in Europe, South East Asia, Japan and Latin America. The company's inherent strength lies in identifying relevant bulk drugs and selling them at affordable prices across the world. The company has given stellar performance in FY22 wherein sales grew by 40% while PAT more than doubled from Rs 4.04 crore to Rs 8.36 crore. ROCE and ROE during FY22 stood at 24.6% and 19%, respectively.

The company’s share price is currently trading at a TTM P/E of 24.9x times, compared to the industry P/E of 31.35x. Shares of Panchsheel Organics have logged 52-week high and low of Rs 235.95 and Rs 42.30, respectively. It enjoys a market capitalisation of Rs 244 crore. 

At 2.50 pm, shares of Panchsheel Organics were quoting Rs 206.95, down 0.53% or Rs 1.10 per share.

Share Market Today

How do you rate this article?


Start Investing in 5 mins*

Rs. 20 Flat Per Order | 0% Brokerage

About the Author

Our research team is composed of some highly qualified research professionals, their expertise range across sectors.


Investment/Trading in securities Market is subject to market risk, past performance is not a guarantee of future performance. The risk of loss in trading and investment in Securities markets including Equites and Derivatives can be substantial.
Open Free Demat Account
Resend OTP
Please Enter OTP
Account belongs to

By proceeding, you agree to the T&C.

Latest News
NSE Awaits SEBI Approval for Extended F&O Trading Hours

The National Stock Exchange (NSE) is considering a significant shift in its trading hours, potentially introducing extended sessions for equity derivatives.

  • Sep 25, 2023
Delta Corp crashes 20%, After Receiving ₹16,822 Crore Tax Notice

Delta Corp Ltd, a prominent gaming company, saw its stock plummet by 20% during the intraday session on the Bombay Stock Exchange (BSE), touching its 52-week low of ₹140.20.

  • Sep 25, 2023
Bajaj Finance Plans $800 Million to $1 Billion Fundraising for Expansion

Bajaj Finance, a leading non-banking financial company (NBFC), is preparing for a fundraising endeavor, aiming to secure between $800 million to $1 billion.

  • Sep 25, 2023